Skip to main content
Log in

Synthesis, Crystal Structure and Anti-leukemic Activity of 4-{4-[(4-(2-Oxo-2,3-dihydro-1H-benzimidazol-1-yl)piperidin-1-yl)benzyl]}-3-phenyl-3H-pyrrolo[2,3-c]quinoline

  • Brief Communication
  • Published:
Journal of Chemical Crystallography Aims and scope Submit manuscript

Abstract

The title compound 4-{4-[(4-(2-oxo-2,3-dihydro-1H-benzimidazol-1-yl)piperidin-1-yl)benzyl]}-3-phenyl-3H-pyrrolo[2,3-c]quinoline 1, a compound that showed cytotoxic potential against two leukemia cell lines, has been synthesized via a multi-step pathway. This compound was characterized by single-crystal X-ray diffraction, IR, MS, elemental analysis, 1H and 13C NMR. The crystal (C37H33H5O, Mr = 563.68) belongs to orthorhombic, space group Pbcn with cell parameters a = 30.198(2) Å, b = 12.5097(11) Å, c = 15.6648(13) Å, V = 5917.7(8) Å3, Z = 8, Dc = 1.265 g/cm3, CuKα radiation, λ = 1.54180 Å, µ = 0.611 mm−1, F(000) = 2384, the final R = 0.0491 and wR = 0.1585 for 5698 observed reflections with I > 2σ(I).

Graphical Abstract

The antileukemial 4-{4-[(4-(2-oxo-2,3-dihydro-1H-benzimidazol-1-yl)piperidin-1-yl)benzyl]}-3-phenyl-3H-pyrrolo[2,3-c]quinoline was synthesized and characterized by X-ray crystallography.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Scheme 1
Fig. 1
Fig. 2

References

  1. Lichtman MA (2008) Oncologist 13:126

    Article  PubMed  Google Scholar 

  2. Carroll AR, Duffy S, Avery VM (2010) J Org Chem 75:8291

    Article  CAS  PubMed  Google Scholar 

  3. Okanya PW, Mohr KI, Gerth K, Jansen R, Mueller R (2011) J Nat Prod 74:603

    Article  CAS  PubMed  Google Scholar 

  4. Mhaske SB, Lande JR (2013) WO 2013117986

  5. Campos Aguiar AC, Panciera M, Simao dos Santos EF, Singh MK, Garcia ML, Eduardo de Souza G, Nakabashi M, Costa JL, Garcia CRS, Oliva G, Roque Duarte Correia C, Carvalho Guido RV (2018) J Med Chem 61:5547

    Article  CAS  Google Scholar 

  6. Akula M, Sridevi JP, Yogeeswari P, Sriram D, Bhattacharya A (2014) Monatsh Chem 145:811

    Article  CAS  Google Scholar 

  7. Panarese JD, Lindsley CW (2012) Org Lett 14:5808

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Desplat V, Moreau S, Gay A, Belisle-Fabre S, Thiolat D, Massip S, Mossalayi D, Jarry C, Guillon J (2010) J Enzyme Inhib Med Chem 25:204

    Article  CAS  PubMed  Google Scholar 

  9. Desplat V, Moreau S, Belisle-Fabre S, Thiolat D, Uranga J, Lucas R, Massip S, de Moor L, Jarry C, Mossalayi D, Sonnet P, Déléris G, Guillon J (2011) J Enzyme Inhib Med Chem 26:657

    Article  CAS  PubMed  Google Scholar 

  10. Desplat V, Vincenzi M, Lucas R, Moreau S, Savrimoutou S, Pinaud N, Lesbordes J, Peyrilles E, Marchivie M, Routier S, Sonnet P, Rossi F, Ronga L, Guillon J (2016) Eur J Med Chem 113:214

    Article  CAS  PubMed  Google Scholar 

  11. Guillon J, Vincenzi M, Pinaud N, Ronga L, Rossi F, Savrimoutou S, Moreau S, Desplat V, Marchivie M (2016) Struct Chem Crystallogr Commun 2:18

    Google Scholar 

  12. Desplat V, Vincenzi M, Lucas R, Moreau S, Savrimoutou S, Rubio S, Pinaud N, Bigat D, Enriquez E, Marchivie M, Routier S, Sonnet P, Rossi F, Ronga L, Guillon J (2017) ChemMedChem 12:940

    Article  CAS  PubMed  Google Scholar 

  13. Barton DHR, Kervagoret J, Zard SZ (1990) Tetrahedron 46:7587

    Article  CAS  Google Scholar 

  14. Alazard JP, Boye O, Gillet B, Guenard D, Beloeil JC, Thal C (1993) Bull Soc Chim Fr 130:779

    CAS  Google Scholar 

  15. Sheldrick GM (2008) Acta Crystallogr Sect A 64:112

    Article  CAS  Google Scholar 

  16. Dolomanov OV, Bourhis LJ, Gildea RJ, Howard JAK, Puschmann H (2009) J Appl Crystallogr 42:339

    Article  CAS  Google Scholar 

  17. Inaba S, Akatsu M, Hirohashi T, Yamamoto H (1976) Chem Pharm Bull 24:1076

    Article  CAS  PubMed  Google Scholar 

  18. Allen FH, Kennard O, Watson DG, Brammer L, Orpen AG, Taylor R (1987) J Chem Soc Perkin Trans 2: S1

    Article  Google Scholar 

  19. Kanjana-opas A, Panphon S, Fun HK, Chantrapromma S (2006) Acta Crystallogr Sect E E62:o2728

    Article  CAS  Google Scholar 

Download references

Acknowledgements

This publication was supported by a grant from Ligue Contre le Cancer (Comité Aquitaine-Charentes, Bordeaux, France).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jean Guillon.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Guillon, J., Moreau, S., Desplat, V. et al. Synthesis, Crystal Structure and Anti-leukemic Activity of 4-{4-[(4-(2-Oxo-2,3-dihydro-1H-benzimidazol-1-yl)piperidin-1-yl)benzyl]}-3-phenyl-3H-pyrrolo[2,3-c]quinoline. J Chem Crystallogr 49, 106–112 (2019). https://doi.org/10.1007/s10870-018-0734-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10870-018-0734-2

Keywords

Navigation